J3 Bioscience Overview
- Year Founded
-
2007

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$645K
- Investors
-
2
J3 Bioscience General Information
Description
Developer of a biomedical device designed to help improve female reproductive health. The company's device specializes in creating an intravaginal ring that is intended as a long-lasting vaginal lubricating moisturizer and provides a method to enhance the ease and comfort of sexual activity and supplement the body's natural lubrication that continuously delivers moisture and contains no hormones or drugs, enabling women to maintain vaginal health.
Contact Information
Website
www.j3bio.comCorporate Office
- Northgate Park, 825 North 300 West
- Suite N231
- Salt Lake City, UT 84103
- United States
Corporate Office
- Northgate Park, 825 North 300 West
- Suite N231
- Salt Lake City, UT 84103
- United States
J3 Bioscience Timeline
J3 Bioscience Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC | 29-Jan-2025 | $645K | Completed | Generating Revenue | ||
8. Later Stage VC | 07-Jun-2023 | Completed | Generating Revenue | |||
7. Later Stage VC (Series B) | 01-Nov-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series A3) | 11-May-2021 | Completed | Generating Revenue | |||
5. Later Stage VC (Series A2) | 18-Dec-2019 | Completed | Generating Revenue | |||
4. Later Stage VC (Series A1) | 28-Aug-2017 | Completed | Generating Revenue | |||
3. Seed Round | 23-Nov-2015 | Completed | Generating Revenue | |||
2. Seed Round | 29-Nov-2012 | $700K | $1M | Completed | Generating Revenue | |
1. Angel (individual) | 18-Jul-2007 | $300K | $300K | Completed | Generating Revenue |
J3 Bioscience Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-3 | ||||||||
Series A-2 | ||||||||
Series A-1 | ||||||||
Seed II | 1,400,000 | $0.010000 | $0.6 | $0.6 | 1x | $0.6 | 9.88% | |
Seed I | 4,400,000 | $0.010000 | $0.3 | $0.3 | 1x | $0.3 | 31.04% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
J3 Bioscience Comparisons
Industry
Financing
Details
J3 Bioscience Competitors (3)
One of J3 Bioscience’s 3 competitors is Good Clean Love, a Private Equity-Backed company based in Eugene, OR.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Good Clean Love | Private Equity-Backed | Eugene, OR | ||||
NeuEve | Corporation | Arlington Heights, IL | ||||
Bonafide Health | Formerly PE-Backed | Harrison, NY |
J3 Bioscience Signals
J3 Bioscience Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Salt Lake Life Science Angels | Angel Group | Minority | ||
TCA Venture Group | Angel Group | Minority |
J3 Bioscience FAQs
-
When was J3 Bioscience founded?
J3 Bioscience was founded in 2007.
-
Where is J3 Bioscience headquartered?
J3 Bioscience is headquartered in Salt Lake City, UT.
-
What is the size of J3 Bioscience?
J3 Bioscience has 5 total employees.
-
What industry is J3 Bioscience in?
J3 Bioscience’s primary industry is Therapeutic Devices.
-
Is J3 Bioscience a private or public company?
J3 Bioscience is a Private company.
-
What is J3 Bioscience’s current revenue?
The current revenue for J3 Bioscience is
. -
How much funding has J3 Bioscience raised over time?
J3 Bioscience has raised $6.28M.
-
Who are J3 Bioscience’s investors?
Salt Lake Life Science Angels and TCA Venture Group have invested in J3 Bioscience.
-
Who are J3 Bioscience’s competitors?
Good Clean Love, NeuEve, and Bonafide Health are competitors of J3 Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »